Abstract: A system is disclosed for securely communicating between a user device and a target device, which includes a user input receiving user inputs and a user device memory for storing at least one fixed dataset having a plurality of data bits and an inherent entropy. At least one predetermined harvest process is stored in ser device memory, which is operable within a main harvest process to distill the dataset to a predetermined bit length to define a private key of the user at a predetermined key length.

Abstract: A system is disclosed for securely communicating between a user device and a target device, which includes a user input receiving user inputs and a user device memory for storing at least one fixed dataset having a plurality of data bits and an inherent entropy. At least one predetermined harvest process is stored in ser device memory, which is operable within a main harvest process to distill the dataset to a predetermined bit length to define a private key of the user at a predetermined key length.

Abstract: A system is disclosed for securely communicating between a user device and a target device, which includes a user input receiving user inputs and a user device memory for storing at least one fixed dataset having a plurality of data bits and an inherent entropy. At least one predetermined harvest process is stored in ser device memory, which is operable within a main harvest process to distill the dataset to a predetermined bit length to define a private key of the user at a predetermined key length.

Abstract: A system is disclosed for securely communicating between a user device and a target device, which includes a user input receiving user inputs and a user device memory for storing at least one fixed dataset having a plurality of data bits and an inherent entropy. At least one predetermined harvest process is stored in ser device memory, which is operable within a main harvest process to distill the dataset to a predetermined bit length to define a private key of the user at a predetermined key length.

Abstract: A system is disclosed for securely communicating between a user device and a target device, which includes a user input receiving user inputs and a user device memory for storing at least one fixed dataset having a plurality of data bits and an inherent entropy. At least one predetermined harvest process is stored in ser device memory, which is operable within a main harvest process to distill the dataset to a predetermined bit length to define a private key of the user at a predetermined key length.

Abstract: A system is disclosed for securely communicating between a user device and a target device, which includes a user input receiving user inputs and a user device memory for storing at least one fixed dataset having a plurality of data bits and an inherent entropy. At least one predetermined harvest process is stored in ser device memory, which is operable within a main harvest process to distill the dataset to a predetermined bit length to define a private key of the user at a predetermined key length.

Abstract: The present invention defines the parameters whereby “quantification” of isotope emission may occur and be clinically applied and provides a method for detecting abnormal coronary blood flow by “quantifying” emissions of a radiopharmaceutical after stressing the heart either pharmacologically or physiologically under “same state” conditions of stress-stress for detection of ischemic vascular (IVD) disease and the ability to differentiate (a) ischemic heart disease (IHD) due to narrowed coronary lumen and subsequent reduced lumen responsiveness to demand for more coronary blood flow and (b) vulnerable inflammatory plaque (VIP) disease, which reduces lumen responsiveness to blood flow demand with potential for sudden rupture and sudden cardiac death.

Abstract: The present invention provides a method for detecting abnormal coronary blood flow by “quantifying” emissions of radiopharmaceuticals after stressing the heart under “same state” conditions for detection of inflammatory vascular (IVD) disease and differentiation of (a) ischemic heart disease due reduced lumen responsiveness to demand for more coronary blood flow and (b) vulnerable inflammatory plaque disease with reduced lumen responsiveness. The present invention also provides a method for detection of myocyte viability by using the “quantitative” method to differentiate “normal” functioning cardiac tissue from non-viable “infarcted” cardiac tissue, from “stunned/hibernating” myocytes. The present invention further provides a method for detection of IVD by detecting enhanced thymic activity associated with IVD.

Abstract: The invention provides a novel quantitative method for differentiating and identification of changes in tissue by enhancing differences in blood flow prior to administering a radiopharmaceutical, which differentially accumulates in tissue based upon differences in blood flow and metabolic activity. In one embodiment the enhancing agent is 0.852 mg per kilogram body weight dipyridamole and the radiopharmaceutical is Technetium-99m hexakis 2-methoxyisobutylisonitrile (sestamibi) and the tissue differentiation is calcification, normal, inflammatory, precancerous and cancerous breast tissue. The present invention allows differentiation between regions of calcification, nonliving or metabolically inactive tissue, normal tissue, pre-cancerous and cancerous tissue. The present invention allows for quantification of changes in tissue to determine the effect of treatment upon tissue.

Abstract: The present invention provides a method for detecting abnormal coronary blood flow by “quantifying” emissions of radiopharmaceuticals after stressing the heart under “same state” conditions for detection of inflammatory vascular (IVD) disease and differentiation of (a) ischemic heart disease due reduced lumen responsiveness to demand for more coronary blood flow and (b) vulnerable inflammatory plaque disease with reduced lumen responsiveness. The present invention also provides a method for detection of myocyte viability by using the “quantitative” method to differentiate “normal” functioning cardiac tissue from non-viable “infarcted” cardiac tissue, from “stunned/hibernating” myocytes. The present invention further provides a method for detection of IVD by detecting enhanced thymic activity associated with IVD.